Drug intelligence / Profile preview

CellerateRX

Development stage
Phase 3
Lead developer
Sanara MedTech
Modality
Device-based Delivery → Drug Delivery Systems, Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

CellerateRX is a wound care product composed of hydrolyzed Type I bovine collagen fragments. It is indicated for the management of surgical wounds, traumatic wounds, partial- and full-thickness wounds, first- and second-degree burns, as well as chronic and acute wounds including pressure injuries (stages 1–4), venous stasis ulcers, arterial ulcers, diabetic ulcers, and superficial wounds. The hydrolyzed collagen fragments are approximately 1/1000th the size of native collagen molecules; this allows them to be readily available to aid in the natural wound healing process without requiring further breakdown by the body. The product provides a moist environment conducive to healing and can be used in various forms (powder or gel) depending on wound exudation levels[1][2][3][4][5][7].

Brand names
CellerateRX
Other names
CellerateCellerateRX Surgical PowderCellerateRX Gel
02

Targets

pECM (Provisional extracellular matrix)

Beyond the preview

Go deeper on CellerateRX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CellerateRX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call